XLO
Xilio Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.89 / 10Overall Score
NeturalInvestment Rating
4.89 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of XLO
- Based on a composite score of 4.89/10, we rate XLO as a Netural. Our analysis breaks down into 7.33/10 for Fundamentals, 1.58/10 for Technicals, and 5.33/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of XLO?
Is XLO undervalued or overvalued?
Is money flowing into or out of XLO?
Trend Analysis of XLO
- Based on a composite score of 4.89/10, we rate XLO as a Netural. Our analysis breaks down into 7.33/10 for Fundamentals, 1.58/10 for Technicals, and 5.33/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is XLO undervalued or overvalued?
Technical Analysis of XLO?
Is money flowing into or out of XLO?
